Details of the Drug Combinations

General Information of This Drug (ID: DMVDYTG)

Drug Name

CPG 52364 DMVDYTG

Synonyms

SCHEMBL5049937

Indication

Disease Entry	ICD 11	Status	REF
Systemic lupus erythematosus	4A40.0	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

6 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
CPG 52364 + Gefitinib	DC6A7MN	Gefitinib	Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)	[2]
CPG 52364 + Mebendazole	DCPRIX7	Mebendazole	Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)	[2]
Dasatinib + CPG 52364	DCHQTW2	Dasatinib	Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)	[2]
Dorsomorphin + CPG 52364	DCLHALR	Dorsomorphin	Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)	[2]
KN-62 + CPG 52364	DCIMPNE	KN-62	DD2 (Cell Line: DD2)	[2]
SCH 727965 + CPG 52364	DCKEPJA	SCH 727965	Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)	[2]
------------------------------------------------------------------------------------


⏷ Show the Full List of 6 DrugCom(s)

References

1	Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys. Nat Rev Rheumatol. 2014 Jan;10(1):23-34.
2	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.